Mymd Pharmaceuticals Inc logo

Mymd Pharmaceuticals Inc Share Price (NASDAQ: MYMD)

▲

-1.82

(-100%)

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 23 Jul 2024

Check the interactive Mymd Pharmaceuticals Inc Stock chart to analyse performance

Mymd Pharmaceuticals Inc Key Stats

Check Mymd Pharmaceuticals Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.82
Open
$1.79
Market Capitalization
$4.3M
Today's Volume
$24.3K
Revenue TTM
$0.0
EBITDA
$-28.2M
Earnings Per Share (EPS)
$-9.27
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-101.36%

Global Institutional Holdings in Mymd Pharmaceuticals Inc

  • Name

    Holdings %

  • UBS Group AG

    0.67%

  • Geode Capital Management, LLC

    0.61%

  • Vanguard Group Inc

    0.59%

  • Virtu Financial LLC

    0.49%

  • BlackRock Inc

    0.16%

  • Parallel Advisors, LLC

    0.04%

Analyst Recommendation on Mymd Pharmaceuticals Inc Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Mymd Pharmaceuticals Inc(by analysts ranked 0 to 5 stars)

About Mymd Pharmaceuticals Inc

MyMD Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company. It focuses on developing two novel therapeutic platforms that treat the causes of disease rather than addressing the symptoms. Its MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. The MYMD-1 is being developed to delay aging, increase longevity, and treat autoimmune diseases. The company's second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction, and epilepsy. The Supera-CBD is a novel synthetic derivative of cannabidiol (CBD) and is being developed to address and improve the growing CBD market, which includes FDA approved drugs and CBD products not regulated as drugs. The company was founded in 2014 and is headquartered in Baltimore, Maryland.
Organization
Mymd Pharmaceuticals Inc
Employees
6
CEO
Mr. Ian Rhodes CPA
Industry
Miscellaneous

Important FAQs about investing in MYMD Stock from India :

What is Mymd Pharmaceuticals Inc share price today?

Mymd Pharmaceuticals Inc share price today is as on at the close of the market. Mymd Pharmaceuticals Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Mymd Pharmaceuticals Inc share?

Mymd Pharmaceuticals Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Mymd Pharmaceuticals Inc stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Mymd Pharmaceuticals Inc Stock (MYMD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Mymd Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Mymd Pharmaceuticals Inc Shares .

What is the minimum amount required to buy Mymd Pharmaceuticals Inc Stock (MYMD) from India?

Indian investors can start investing in Mymd Pharmaceuticals Inc (MYMD) shares with as little as ₹87.7613 or $1 (as of September 18, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹877.61 in Mymd Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025). Learn more about fractional shares .

What are the returns that Mymd Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Mymd Pharmaceuticals Inc stock has given 0.0% share price returns and 19.34% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?